During the past decade, Centre Leonard de Vinci conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Leonard de Vinci" #1 sponsor was "Centre Oscar Lambret" with 12 trials, followed by "Hoffmann-La Roche" with 8 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 3 trials sponsored, "UNICANCER" with 3 trials sponsored and "Institut de Cancérologie de la Loire" with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Leonard de Vinci" #1 collaborator was "Canceropôle Nord Ouest" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "National Cancer Institute, France" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator and "Aix Marseille Université" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Centre Leonard de Vinci" are "Breast Cancer" (12 trials), "Colorectal Cancer" (4 trials), "Metastatic Breast Cancer" (2 trials), "Metastatic Prostate Cancer" (2 trials) and "Aging" (1 trials). Many other conditions were trialed in "Centre Leonard de Vinci" in a lesser frequency.

Most popular intervention types in "Centre Leonard de Vinci" are "Drug" (17 trials), "Radiation" (7 trials), "Other" (4 trials), "Behavioral" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Trastuzumab" (6 trials), "Docetaxel" (5 trials), "Bevacizumab" (3 trials), "Paclitaxel" (3 trials) and "5-Fluorouracil" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre Leonard de Vinci" are 17 trials for "All" genders, 11 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Leonard de Vinci". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Centre Leonard de Vinci, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Leonard de Vinci, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".